Addex Therapeutics Ltd ADXN
ADXN
Addex Therapeutics Ltd VYNE
VYNE Therapeutics Inc. QLGN
Qualigen Therapeutics, Inc. NLSP
NLS Pharmaceutics AG ENSC
Ensysce Biosciences, Inc. BCLI
Brainstorm Cell Therapeutics Inc. ALZN
Alzamend Neuro, Inc. NBY
NovaBay Pharmaceuticals, Inc. NRSN
NeuroSense Therapeutics Ltd. AIM
AIM ImmunoTech Inc.
Addex Therapeutics Ltd VYNE
VYNE Therapeutics Inc. QLGN
Qualigen Therapeutics, Inc. NLSP
NLS Pharmaceutics AG ENSC
Ensysce Biosciences, Inc. BCLI
Brainstorm Cell Therapeutics Inc. ALZN
Alzamend Neuro, Inc. NBY
NovaBay Pharmaceuticals, Inc. NRSN
NeuroSense Therapeutics Ltd. AIM
AIM ImmunoTech Inc.
Performance
| Periode | ADXN | VYNE | QLGN | NLSP | ENSC | BCLI | ALZN | NBY | NRSN | AIM |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 22.24 % | -77.71 % | 22.90 % | 22.76 % | 26.02 % | -11.09 % | -68.45 % | 87.57 % | 14.35 % | -11.67 % |
| YTD | 13.00 % | -88.29 % | -9.29 % | -18.35 % | -70.06 % | -67.76 % | -79.26 % | 68.00 % | 7.39 % | -87.95 % |
| 1Y | -18.86 % | -80.60 % | -54.75 % | -61.22 % | -3.14 % | -68.49 % | -85.19 % | 70.73 % | 13.30 % | -89.81 % |
| 3Y | -46.75 % | -91.08 % | -97.17 % | -91.44 % | -99.67 % | -98.68 % | -99.84 % | -99.20 % | -27.78 % | -94.70 % |
| 5Y | -96.51 % | -99.71 % | -99.84 % | -98.46 % | -99.99 % | -99.72 % | -99.99 % | -99.89 % | -69.43 % | -98.92 % |
| 10Y | -96.23 % | -99.98 % | -100.00 % | -98.46 % | -99.99 % | -98.35 % | -99.99 % | -99.99 % | -69.43 % | -99.97 % |
| From the beginning | -96.23 % | -99.98 % | -100.00 % | -98.46 % | -99.99 % | -72.73 % | -99.99 % | -100.00 % | -69.43 % | -71.10 % |